Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 1, 2017

DrugPatentWatch Database Preview

Lanthanum carbonate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for lanthanum carbonate and what is the scope of lanthanum carbonate freedom to operate?

Lanthanum carbonate
is the generic ingredient in one branded drug marketed by Shire Dev Llc and Shire Llc, and is included in two NDAs. There are five patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Lanthanum carbonate has one hundred patent family members in thirty-five countries.

There are eight drug master file entries for lanthanum carbonate. Three suppliers are listed for this compound.

Summary for Generic Name: lanthanum carbonate

Drug Master File Entries: see list8
Suppliers / Packagers: see list3
Bulk Api Vendors: see list18
Clinical Trials: see list69
Patent Applications: see list1
Therapeutic Class:Genitourinary Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:lanthanum carbonate at DailyMed

Pharmacology for Ingredient: lanthanum carbonate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Shire Dev Llc
lanthanum carbonate
POWDER;ORAL204734-002Sep 24, 2014RXYesYes7,465,465► SubscribeY ► Subscribe
Shire Llc
lanthanum carbonate
TABLET, CHEWABLE;ORAL021468-004Nov 23, 2005RXYesYes7,465,465► SubscribeY ► Subscribe
Shire Dev Llc
lanthanum carbonate
POWDER;ORAL204734-001Sep 24, 2014RXYesNo9,023,397► SubscribeY ► Subscribe
Shire Llc
lanthanum carbonate
TABLET, CHEWABLE;ORAL021468-002Oct 26, 2004RXYesNo7,465,465► SubscribeY ► Subscribe
Shire Llc
lanthanum carbonate
TABLET, CHEWABLE;ORAL021468-003Nov 23, 2005RXYesNo7,465,465► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus